| Lab Research Using Mini-tumors to Study Prostate Cancer Treatments (NCT07004582) | Maastricht Radiation Oncology | 2026-03-15 |
| Re-induction of a Systemic Immune Response in Metastatic or Locally Recurrent Lung Cancer (NCT06024941) | Maastricht Radiation Oncology | 2024-12-01 |
| Feasibility of the Maastro Applicator in Rectal Cancer (NCT06087718) | Maastricht Radiation Oncology | 2024-08-27 |
| In Vivo Treatment Verification of Brachytherapy (NCT06240559) | Maastricht Radiation Oncology | 2024-02-29 |
| Precision Radiation Treatment for Epilepsy (PRECISION) (NCT05182437) | Maastricht Radiation Oncology | 2023-12-01 |
| The Addition of Chloroquine to Chemoradiation for Glioblastoma, (NCT02432417) | Maastricht Radiation Oncology | 2023-11-10 |
| Standard of Care Lifestyle Support for Stage III NSCLC Patients (NCT05287971) | Maastricht Radiation Oncology | 2023-08-01 |
| The Effect of 360° Virtual Reality Movies on Fear and Anxiety (NCT06199050) | Maastricht Radiation Oncology | 2023-06-16 |
| Lung Cancer Organoids and Patient Derived Tumor Xenografts (NCT05092009) | Maastricht Radiation Oncology | 2022-10-05 |
| Developing Breast (Cancer) Organoids (NCT05317221) | Maastricht Radiation Oncology | 2022-09-01 |
| DETECT: Target Volume for Rectal Endoluminal Radiation Boosting (NCT04927897) | Maastricht Radiation Oncology | 2022-08-16 |
| Effect of stRess and exeRcize on the Outcome After Chemo-Radiation (NCT05431348) | Maastricht Radiation Oncology | 2022-06-01 |
| A Living Tissue Bank of Patient-Derived Organoids From Glioma Tumors (NCT04865315) | Maastricht Radiation Oncology | 2022-05-01 |
| Predicting Radiological Extranodal Extension in Oropharyngeal Carcinoma Patients Using AI (NCT05565313) | Maastricht Radiation Oncology | 2022-03-22 |
| Spatial Location of Breast Cancer Local Recurrence After Mastectomy (NCT06130111) | Maastricht Radiation Oncology | 2021-09-01 |
| ARtificial Intelligence for Gross Tumour vOlume Segmentation (NCT05775068) | Maastricht Radiation Oncology | 2021-07-01 |
| Patient-derived Glioma Stem Cell Organoids (NCT04868396) | Maastricht Radiation Oncology | 2021-04-10 |
| PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRI (NCT04638478) | Maastricht Radiation Oncology | 2021-04-08 |
| Immune Profiling of Stage III Non-small Cell Lung Cancer Patients Treated With Concurrent Chemoradiation and Adjuvant Durvalumab: A Prospective Observational Phase II Trial (NCT04432142) | Maastricht Radiation Oncology | 2021-04-01 |
| Vestibular Schwannoma Organoids (NCT05786144) | Maastricht Radiation Oncology | 2020-06-01 |
| Personal Health Train for Radiation Oncology in India and The Netherlands (NCT04655469) | Maastricht Radiation Oncology | 2020-04-10 |
| Immune Profiling After HDR in Local Relapsed Prostate Cancer (NCT04247217) | Maastricht Radiation Oncology | 2020-02-19 |
| Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung Cancer (NCT03406468) | Maastricht Radiation Oncology | 2019-07-15 |
| 20K Distributed Learning Challenge (NCT03564457) | Maastricht Radiation Oncology | 2018-07-01 |
| BioXmark, Rectal Feasibility Trial (NCT03265418) | Maastricht Radiation Oncology | 2018-01-02 |
| Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology (NCT04648462) | Maastricht Radiation Oncology | 2018-01-01 |
| Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients (NCT03385031) | Maastricht Radiation Oncology | 2018-01-01 |
| Prospective Primary Human Lungcancer Organoids to Predict Treatment Response (NCT04859166) | Maastricht Radiation Oncology | 2017-11-15 |